Literature DB >> 9660424

Induction of spermatogenesis and achievement of pregnancy after microsurgical varicocelectomy in men with azoospermia and severe oligoasthenospermia.

G J Matthews1, E D Matthews, M Goldstein.   

Abstract

OBJECTIVE: To characterize treatment outcome after varicocele repair in men with azoospermia and severe oligoasthenospermia.
DESIGN: Prospective nonrandomized study.
SETTING: University-based medical center. PATIENT(S): Seventy-eight men with a palpable varicocele and absolute azoospermia (n = 22) or severe oligoasthenospermia (n = 56). INTERVENTION(S): Microsurgical varicocelectomy. MAIN OUTCOME MEASURE(S): Sperm count and pregnancy rate. RESULT(S): Twelve (55%) of the 22 men with azoospermia and 35 (69%) of the 51 men with zero motile sperm before surgery had motile sperm observed in their ejaculate after varicocele repair. The total number of motile sperm per ejaculate increased from 0.08 +/- 0.02 x 10(6) before varicocelectomy to 7.2 +/- 2.3 x 10(6) afterward. Twenty-four men (31%) contributed to pregnancies leading to live births (15 unassisted [19%]), including 3 men with azoospermia preoperatively. CONCLUSION(S): Varicocele repair resulted in the induction or enhancement of spermatogenesis for most men with azoospermia or severe oligoasthenospermia. Unassisted pregnancies after varicocele repair in men with profound abnormalities of spermatogenesis are possible. Varicocele repair should be considered for all men with azoospermia and severe oligoasthenospermia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660424     DOI: 10.1016/s0015-0282(98)00108-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  34 in total

Review 1.  The great debate: varicocele treatment and impact on fertility.

Authors:  Matthew A Will; Jason Swain; Mikkel Fode; Jens Sonksen; Gregory M Christman; Dana Ohl
Journal:  Fertil Steril       Date:  2011-01-26       Impact factor: 7.329

2.  Embolization of left spermatic vein in non-obstructive azoospermic men with varicocele: role of FSH to predict the appearance of ejaculated spermatozoa after treatment.

Authors:  S D'Andrea; A V Giordano; S Carducci; L Sacchetti; S Necozione; M Costanzo; A De Gregorio; A Micillo; F Francavilla; S Francavilla; A Barbonetti
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

Review 3.  Management of non-obstructive azoospermia.

Authors:  Koji Chiba; Noritoshi Enatsu; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2016-01-18

Review 4.  The development of surgical sperm extraction and new challenges to improve the outcome.

Authors:  Noritoshi Enatsu; Koji Chiba; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2015-11-27

5.  Relationship between the number of veins ligated in a varicocelectomy with testicular volume, hormonal levels and semen parameters outcome.

Authors:  Fábio Firmbach Pasqualotto; Antônio Marmo Lucon; Plínio Moreira de Góes; Bernardo Passos Sobreiro; Jorge Hallak; Eleonora Bedin Pasqualotto; Sami Arap
Journal:  J Assist Reprod Genet       Date:  2005-06       Impact factor: 3.412

6.  The use of titanium ligation clips in microsurgical subinguinal varicocelectomy.

Authors:  Mustafa Kıraç; Lütfi Tunç; Nuri Deniz; Hasan Biri
Journal:  Turk J Urol       Date:  2013-03

Review 7.  Non-obstructive azoospermia and clinical varicocele: therapeutic options.

Authors:  Saad Elzanaty
Journal:  Int Urol Nephrol       Date:  2013-04-20       Impact factor: 2.370

8.  The effect of microsurgical varicocelectomy on semen parameters in men with non-obstructive azoospermia.

Authors:  Mustafa Kiraç; Nuri Deniz; Hasan Biri
Journal:  Curr Urol       Date:  2012-12-21

9.  Outcome of Loupe-Assisted Sub-inguinal Varicocelectomy in Infertile Men.

Authors:  Selim S Abdelrahman; Bayoumy I Eassa
Journal:  Nephrourol Mon       Date:  2012-06-20

Review 10.  The epidemiology and etiology of azoospermia.

Authors:  Marcello Cocuzza; Conrado Alvarenga; Rodrigo Pagani
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.